Comparison of Tocilizumab vs Baricitinib in Clinical Outcomes Among Hospitalized Patients With COVID-19: Experience From a Public Hospital System in New York City.
Subin SunnyAmi TranJennifer LeeMarie AbdallahNimra ChaudhryJohn QualePublished in: Open forum infectious diseases (2023)
Baricitinib treatment was associated with more favorable respiratory improvement at day 7 when compared with tocilizumab, but no differences were observed up to day 28.